|
|
||||||||
Departments of 1Integrative Physiology and 2Surgery, University of North Texas Health Science Center, and Department of 3Pharmacy, Plaza Medical Center of Fort Worth, Fort Worth, Texas
Submitted 31 March 2005 ; accepted in final form 13 May 2005
Cardioplegic arrest for bypass surgery imposes global ischemia on the myocardium, which generates oxyradicals and depletes myocardial high-energy phosphates. The glycolytic metabolite pyruvate, but not its reduced congener lactate, increases phosphorylation potential and detoxifies oxyradicals in ischemic and postischemic myocardium. This study tested the hypothesis that pyruvate mitigates oxidative stress and preserves the energy state in cardioplegically arrested myocardium. In situ swine hearts were arrested for 60 min with a 4:1 mixture of blood and crystalloid cardioplegia solution containing 188 mM glucose alone (control) or with additional 23.8 mM lactate or 23.8 mM pyruvate and then reperfused for 3 min with cardioplegia-free blood. Glutathione (GSH), glutathione disulfide (GSSG), and energy metabolites [phosphocreatine (PCr), creatine (Cr), Pi] were measured in myocardium, which was snap frozen at 45 min arrest and 3 min reperfusion to determine antioxidant GSH redox state (GSH/GSSG) and PCr phosphorylation potential {[PCr]/([Cr][Pi])}. Coronary sinus 8-isoprostane indexed oxidative stress. Pyruvate cardioplegia lowered 8-isoprostane release
40% during arrest versus control and lactate cardioplegia. Lactate and pyruvate cardioplegia dampened (P < 0.05 vs. control) the surge of 8-isoprostane release following reperfusion. Pyruvate doubled GSH/GSSG versus lactate cardioplegia during arrest, but GSH/GSSG fell in all three groups after reperfusion. Myocardial [PCr]/([Cr][Pi]) was maintained in all three groups during arrest. Pyruvate cardioplegia doubled [PCr]/([Cr][Pi]) versus control and lactate cardioplegia after reperfusion. Pyruvate cardioplegia mitigates oxidative stress during cardioplegic arrest and enhances myocardial energy state on reperfusion.
glutathione; reactive oxygen species; cardioplegia
This article has been cited by other articles:
![]() |
B. Ramlawi, H. Otu, S. Mieno, M. Boodhwani, N. R. Sodha, R. T. Clements, C. Bianchi, and F. W. Sellke Oxidative Stress and Atrial Fibrillation After Cardiac Surgery: A Case-Control Study Ann. Thorac. Surg., October 1, 2007; 84(4): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Sharma, J. Sun, L. L. Howard, A. G. Williams Jr., and R. T. Mallet Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H198 - H206. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Knott, J. Sun, Y. Lei, M.-G. Ryou, A. H. Olivencia-Yurvati, and R. T. Mallet Pyruvate Mitigates Oxidative Stress During Reperfusion of Cardioplegia-Arrested Myocardium. Ann. Thorac. Surg., March 1, 2006; 81(3): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |